Provided by Tiger Trade Technology Pte. Ltd.

4D Molecular Therapeutics

13.33
+0.63004.96%
Post-market: 13.330.00000.00%16:38 EDT
Volume:867.89K
Turnover:11.65M
Market Cap:736.41M
PE:-4.83
High:13.85
Open:12.70
Low:12.55
Close:12.70
52wk High:16.93
52wk Low:6.96
Shares:55.24M
Float Shares:42.02M
Volume Ratio:0.74
T/O Rate:2.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7580
EPS(LYR):-2.4200
ROE:-43.25%
ROA:-25.09%
PB:1.81
PE(LYR):-5.51

Loading ...

Oct 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 28, 2026

Major Issues Report

Form 8-K - Current report
Sep 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Aug 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 20, 2026

Major Issues Report

Form 8-K - Current report
Jul 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]